MedPath

A study on the benefits of nasal breathing support in premature babies

Phase 3
Completed
Conditions
Health Condition 1: J988- Other specified respiratory disordersHealth Condition 2: null- Premature neonates at birth
Registration Number
CTRI/2017/10/010001
Lead Sponsor
Surya Children Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

Preterm infants more than 28 weeks of gestation and/or more than 1 kg birth weight with respiratory distress and FiO2 requirement >30% within first 6 hours of birth.

Exclusion Criteria

1) Birth weight <1000 grams

2)Gestational age <28 weeks

3)Infant who already received surfactant

4)Pneumothorax on Chest X-ray

5)Shock requiring inotropic support, multi organ dysfunction and encephalopathy

6)Abnormalities of upper and lower airways precluding use of HHHFNC (Pierre-Robin, Treacher Collins, Goldenhar, choanal atresia, cleft lip/palate)

7)Serious abdominal, cardiac, or respiratory malformations including tracheal esophageal fistula, intestinal atresia, omphalocele, gastroschisis, or diaphragmatic hernia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HHHFNC failure rate -composite outcome defined by the need of a) CPAP support b) surfactant treatment c) mechanical ventilationTimepoint: from birth until fifth day of postnatal age
Secondary Outcome Measures
NameTimeMethod
1.Duration of respiratory support <br/ ><br>2.Duration of oxygen therapy. <br/ ><br>3.Need of CPAP <br/ ><br>4.Need of surfactant treatment <br/ ><br>5.Need of mechanical ventilation <br/ ><br>6.Mortality due to any cause. <br/ ><br>7.Pulmonary air leaks (pneumothorax, pulmonary interstitial emphysema) <br/ ><br>8. Nasal injuriesTimepoint: from admission until NICU discharge
© Copyright 2025. All Rights Reserved by MedPath